Skip to main content

Table 1 Age-adjusted means and percentages (standard error) of sociodemographic and cardiovascular factors among 7249 U.S. adults aged 20–79 years, by categories of respiratory impairment based on prebronchodilator data, National Health and Nutrition Examination Survey 2007-2010

From: Elevated cardiovascular risk among adults with obstructive and restrictive airway functioning in the United States: a cross-sectional study of the National Health and Nutrition Examination Survey from 2007–2010

 

Respiratory impairment

 
  

Obstructive impairment

   
 

None (N=5792)

Restrictive (N=478)

Mild (N=551)

Moderate/severe/very severe (N=428)

P restrictive‡

P mild OI‡

P moderate/ severe OI‡

Age (years)

42.5 (0.3)

50.1 (0.9)

54.9 (0.7)

55.2 (0.7)

<0.001

<0.001

<0.001

Men (%)

46.5 (0.7)

56.4 (3.1)

66.0 (3.0)

58.4 (3.6)

0.002

<0.001

0.004

Race or ethnicity (%)

       

 White

70.4 (2.3)

54.7 (5.1)

84.1 (2.8)

78.0 (4.4)

0.001

<0.001

0.042

 African American

9.9 (1.0)

9.3 (1.4)

7.9 (1.9)

7.7 (1.6)

   

 Mexican American

9.3 (1.4)

8.8 (1.9)

3.4 (1.1)

1.2 (0.4)

   

 Other

10.4 (1.1)

27.2 (4.0)

4.5 (1.3)

13.1 (3.6)

   

Education (%)

       

 <High school

16.4 (0.9)

19.7 (2.0)

17.2 (2.5)

22.5 (3.4)

   

 High school graduate or equivalent

22.2 (0.9)

25.0 (3.8)

28.4 (3.5)

34.4 (3.8)

   

 >High school (%)

61.4 (1.4)

55.3 (4.1)

54.4 (4.0)

43.1 (4.9)

0.112

0.063

<0.001

Smoking status (%)

       

 Current

18.8 (0.7)

24.2 (3.2)

35.7 (2.4)

48.6 (3.8)

0.081

<0.001

<0.001

 Former

23.0 (0.9)

23.2 (2.8)

26.6 (3.0)

26.4 (3.7)

   

 Never

58.2 (1.2)

52.6 (4.3)

37.8 (3.6)

25.0 (3.4)

   

Cotinine >10 ng/ml (%)

22.9 (0.8)

29.3 (3.5)

44.5 (3.5)

53.1 (4.3)

0.048

<0.001

<0.001

Hypertension (%)

25.1 (0.8)

34.1 (2.9)

25.8 (2.4)

30.8 (3.5)

0.003

0.761

0.101

Total cholesterol ≥5.17 mmol/L (%)

45.2 (0.9)

41.4 (2.6)

43.4 (3.6)

36.8 (3.4)

0.212

0.619

0.027

High-density lipoprotein cholesterol <1.03 mmol/L in men, <1.29 mmol/L in women (%)

32.1 (1.1)

50.2 (2.9)

26.7 (3.2)

36.4 (5.1)

<0.001

0.085

0.397

Non-high-density lipoprotein cholesterol ≥130 mg/dl (%)

62.0 (0.8)

61.8 (2.9)

62.2 (3.6)

53.9 (3.9)

0.946

0.951

0.048

Low-density lipoprotein cholesterol ≥2.59 mmol/L* (%)

67.7 (0.9)

69.0 (4.0)

72.4 (4.9)

61.1 (6.0)

0.747

0.350

0.290

C-reactive protein >3 mg/l (%)

30.1 (0.7)

48.8 (3.1)

22.9 (2.5)

34.1 (4.6)

<0.001

0.010

0.371

FPG ≥7.0 mmol/L or diagnosed diabetes† (%)

9.1 (0.7)

25.8 (3.7)

3.2 (0.7)

10.0 (1.8)

<0.001

<0.001

0.678

Diagnosed diabetes (%)

6.1 (0.5)

18.6 (2.3)

3.9 (0.6)

7.3 (1.3)

<0.001

0.002

0.414

Body mass index ≥30 kg/m2 (%)

35.4 (1.0)

51.4 (2.9)

21.6 (2.7)

30.0 (4.0)

<0.001

<0.001

0.206

Abdominal obesity (%)

53.7 (1.1)

65.1 (2.9)

35.8 (2.9)

50.2 (4.0)

<0.001

<0.001

0.434

Leisure-time physical activity <150 min/week (%)

59.9 (1.5)

69.9 (2.8)

55.3 (3.0)

65.3 (4.3)

0.004

0.210

0.225

Congestive heart failure (%)

0.8 (0.1)

3.2 (0.8)

0.9 (0.2)

—§

0.003

0.550

0.069

10-Year cardiovascular risk†

       

 <10%

77.3 (0.9)

68.9 (3.9)

73.2 (2.3)

68.9 (2.7)

   

 10-20%

14.6 (1.0)

16.4 (2.8)

15.4 (2.2)

14.4 (2.6)

   

 >20%

8.1 (0.5)

14.7 (2.3)

11.4 (1.2)

16.7 (2.0)

0.004

0.012

<0.001

  1. OI obstructive impairment.
  2. *Fasting subsample. Sample sizes are 2537, 220, 270, and 180, respectively.
  3. †Fasting subsample. Sample sizes are 2581, 227, 272, and 183, respectively.
  4. ‡P-values are for comparison with participants with no respiratory impairment.
  5. §Relative standard error >30%.